Notably, the potential of this LEF1-AS1 isoform as an in-hospital mortality biomarker was evaluated in 1286 COVID-19 patients, recruited from four cohorts across Europe and Canada, using a lncRNA-based machine learning model that incorporated age and LEF1-AS1 expression as features [25]. The gene discussed is LEF1; the disease is COVID-19.